Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00990782 · ClinicalTrials.gov registry record · NA
Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment
A NA study of Esophageal Lesion, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 1
- Study location
NCT00990782 is a NA study of Esophageal Lesion that has completed, run by The Cleveland Clinic. The registered enrollment target is 93 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00990782, a NA study of Esophageal Lesion, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 1
- Study location
Study Summary
This study utilizes a disposable capsule endoscope (Pillcam ESO) to assess the condition of a patient's esophagus before and after the RFA procedure, as the injury rate to the esophagus has not been established.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST PillCam ESO Capsule Endoscope
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00990782
The ClinicalTrials.gov registry entry for NCT00990782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Esophageal Lesion appearing as the primary indexed condition, and to 1 intervention - of which PillCam ESO Capsule Endoscope is the first listed.
NCT00990782 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00990782 about?
NCT00990782 is a clinical study titled "Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment". This study utilizes a disposable capsule endoscope (Pillcam ESO) to assess the condition of a patient's esophagus before and after the RFA procedure, as the injury rate to the esophagus has not been established.
What is the current status of trial NCT00990782?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2009-09. Estimated completion is 2010-09.
What conditions does trial NCT00990782 study?
This clinical trial studies the following conditions: Esophageal Lesion.
What interventions are being tested in trial NCT00990782?
The interventions under investigation include: PillCam ESO Capsule Endoscope (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00990782?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00990782 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Lesion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.